Event: | Piper Sandler 34th Annual Healthcare Conference |
Date: | |
Location: | |
Presentation: | |
Webcast: | https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6 |
Event: | |
Date: | |
Location: | Virtual |
Presentation: | |
Webcast: | https://wsw.com/webcast/evercore29/cinc/2336910 |
The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or
About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.
Contacts: | Investors: |
EVP and CFO | ir@CinCor.com |
Source:
2022 GlobeNewswire, Inc., source